CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-11-29 | Hoge Stephen President | Sale 10b5-1 | −1,136 | $79.81 | $91K | 1,575,721 |
| 2023-11-28 | Hoge Stephen President | Exercise or conversion 10b5-1 | +2,411 | 1,576,857 | ||
| 2023-11-28 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −2,411 | 2,411 | ||
| 2023-11-10 | Hoge Stephen President | Sale 10b5-1 | −263 | $68.76 | $18K | 1,574,446 |
| 2023-11-09 | Hoge Stephen President | Exercise or conversion 10b5-1 | +522 | 1,574,709 | ||
| 2023-11-09 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units 10b5-1 | −522 | 2,612 | ||
| 2023-11-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,900 | $75.30 | $143K | 2,155,031 |
| 2023-11-01 | AFEYAN NOUBAR Director | Sale 10b5-1 | −8,100 | $76.17 | $617K | 2,146,931 |
| 2023-10-25 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,500 | $76.73 | $499K | 2,160,431 |
| 2023-10-25 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,100 | $77.34 | $240K | 2,157,331 |
| 2023-10-25 | AFEYAN NOUBAR Director | Sale 10b5-1 | −400 | $78.42 | $31K | 2,156,931 |
| 2023-10-11 | AFEYAN NOUBAR Director | Sale 10b5-1 | −8,700 | $102.88 | $895K | 2,173,231 |
| 2023-10-11 | AFEYAN NOUBAR Director | Sale 10b5-1 | −5,700 | $103.76 | $591K | 2,167,531 |
| 2023-10-11 | AFEYAN NOUBAR Director | Sale 10b5-1 | −500 | $104.82 | $52K | 2,167,031 |
| 2023-10-11 | AFEYAN NOUBAR Director | Sale 10b5-1 | −100 | $105.58 | $11K | 2,166,931 |
| 2023-10-06 | Mock James M Chief Financial Officer | Sale 10b5-1 | −2,858 | $102.50 | $293K | 2,952 |
| 2023-10-05 | Mock James M Chief Financial Officer | Exercise or conversion 10b5-1 | +5,810 | 5,810 | ||
| 2023-10-05 | Mock James M Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −5,810 | 17,432 | ||
| 2023-10-04 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,030 | $100.02 | $103K | 2,195,901 |
| 2023-10-04 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,800 | $100.94 | $182K | 2,194,101 |
Page 37 of 38 · 743 trades